Aerovate Therapeutics (AVTE) Stock Chart & Stock Price History $2.68 -0.01 (-0.37%) As of 01/3/2025 05:21 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Aerovate Therapeutics Stock Price Performance 5 Day Performance+1.13%1 Month Performance+4.69%3 Month Performance+30.73%6 Month Performance+66.46%Year-To-Date Performance+1.13%1 Year Performance-86.33% Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address AVTE Stock Chart for Sunday, January, 5, 2025 AVTE Chart by TradingView Aerovate Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/03/2025$2.68$2.68$2.73$2.66311,813 shs$77.39 million01/02/2025$2.65$2.68+1.13%$2.70$2.65154,170 shs$77.39 million01/01/2025$2.65$2.65$2.70$2.6183,274 shs$76.52 million12/31/2024$2.66$2.65-0.38%$2.70$2.6183,274 shs$76.52 million12/30/2024$2.67$2.66-0.37%$2.70$2.6360,530 shs$76.81 million12/27/2024$2.63$2.67+1.52%$2.69$2.56110,707 shs$77.10 million Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/26/2024$2.60$2.63+1.15%$2.67$2.54129,629 shs$75.94 million12/25/2024$2.60$2.60$2.61$2.5475,289 shs$75.08 million12/24/2024$2.56$2.60+1.56%$2.61$2.5475,289 shs$75.08 million12/23/2024$2.53$2.56+1.19%$2.59$2.53270,439 shs$73.92 million12/20/2024$2.53$2.53$2.64$2.45768,549 shs$73.05 million12/19/2024$2.53$2.53$2.59$2.51215,532 shs$73.05 million12/18/2024$2.56$2.53-1.17%$2.63$2.50167,788 shs$73.05 million12/17/2024$2.56$2.56$2.63$2.5292,236 shs$73.92 million12/16/2024$2.53$2.56+1.19%$2.59$2.52132,702 shs$73.92 million12/13/2024$2.56$2.53-1.17%$2.58$2.52199,824 shs$73.07 million12/12/2024$2.60$2.56-1.54%$2.61$2.51161,532 shs$73.92 million12/11/2024$2.63$2.60-1.14%$2.64$2.5890,772 shs$75.08 million12/10/2024$2.69$2.63-2.23%$2.68$2.6192,784 shs$75.94 million12/09/2024$2.67$2.69+0.75%$2.71$2.67189,971 shs$77.69 million12/06/2024$2.56$2.67+4.30%$2.67$2.58197,946 shs$77.10 million12/05/2024$2.55$2.56+0.39%$2.60$2.53145,718 shs$73.93 million12/04/2024$2.62$2.55-2.67%$2.65$2.54342,681 shs$73.64 million Related Companies Voyager Therapeutics Stock Chart Immutep Stock Chart Canopy Growth Stock Chart Atyr PHARMA Stock Chart Benitec Biopharma Stock Chart SNDL Stock Chart Rezolute Stock Chart Atea Pharmaceuticals Stock Chart Lifecore Biomedical Stock Chart iTeos Therapeutics Stock Chart Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTE) was last updated on 1/5/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAmazon coin set to soar 25X – starting January 20thThis tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
